期刊文献+

卡维地洛自乳化分散片的制备及质量评价 被引量:2

Preparation and evaluation of Carvedilol Self-emulsifying Dispersible Tablets
下载PDF
导出
摘要 目的制备卡维地洛自乳化分散片并评价其质量。方法筛选可在45 min内完全释药的固体吸附材料,以粉末直接压片法制备自乳化分散片,通过单因素实验优化处方,考察所得分散片的质量。结果以微晶纤维素KG 802(MCC KG 802)作为固体吸附材料,能有效吸附卡维地洛自微乳并形成固体吸附混合物(Mix)。分散片处方(质量分数)为:20%Mix,6%交联聚维酮(PVPP),3.5%微粉硅胶,0.5%硬脂酸镁与70%微晶纤维素102(MCC 102)。制得的分散片的片质量为300 mg,硬度、脆碎度和分散均匀性均符合要求,在去离子水中分散后形成的微乳粒径与液体自微乳相当。结论制得的卡维地洛自乳化分散片的质量符合要求且较好地保持了液体自微乳的特性。 Objective To establish preparation methods of Carvedilol Self-emulsifying Dispersible Tablets and evaluate their qualities in vitro.Methods The Carvedilol Self-emulsifying Dispersible Tablets were prepared by using direct powder compression method.Solid adsorbent materials which can completely release drug within 45 min were screened,and the formulation of dispersible tablets was optimized by single factor experiments.Results Microcrystalline cellulose KG 802(MCC KG 802)was selected as the suitable solid adsorbent which can effectively absorb the carvedilol self-emulsifying formulation and form solid adsorption mixture(Mix).The final formulation was 20%of Mix,6%of crosslinked polyvinylpyrrolidone(PVPP)as disintegrating agent,3.5%of micro-powder silica gel and 0.5%of magnesium stearate as lubricant,and the remaining was 70%of microcrystalline cellulose 102(MCC 102).The mass of the dispersed tablet was 300 mg.The hardness,friability,uniform dispersion and disintegration time of the tablets was qualified.In vitro study showed that the dispersible tablets could disperse in distilled water and form microemulsion with average particle size comparable to liquid carvedilol self-emulsion.Conclusion The Carvedilol Self-emulsifying Dispersible Tablets was successfully prepared and the characteristics of liquid carvedilol self-emulsion was almost kept.
作者 刘晓庆 柴夫娟 王翠红 赵梅珍 郑春丽 夏胜利 LIU Xiaoqing;CHAI Fujuan;WANG Cuihong;ZHAO Meizhen;ZHENG Chunli;XIA Shengli(Shanghai University ofMedicine&Health Sciences Affiliated Zhoupu Hospital,Shanghai 201318,China;School of Pharmacy,China Pharmaceutical University,Nanjing 210009,China)
出处 《西北药学杂志》 CAS 2020年第5期701-706,共6页 Northwest Pharmaceutical Journal
基金 上海市浦东新区卫生和计划生育委员会领先人才培养计划资助项目(编号:PWR12018-09) 上海健康医学院种子基金资助项目(编号:SFP-18-22-17-004) 上海市浦东新区中医药研发专项资助项目(编号:PDZYYFCX-201818)。
关键词 卡维地洛 自乳化 分散片 质量评价 carvedilol self-emulsifying dispersible tablet quality evaluation
  • 相关文献

参考文献4

二级参考文献26

  • 1赵鑫,刘建平,朱家壁.茶碱微乳经皮吸收及药代动力学研究[J].中国药科大学学报,2006,37(1):28-32. 被引量:24
  • 2姚静,卢韵,周建平,平其能.川陈皮素自微乳的制备及其大鼠在体肠吸收动力学[J].中国药科大学学报,2007,38(1):35-38. 被引量:28
  • 3Dulin B, Abraham W T. Pharmacology of carvedilol [ J ]. Am J Cardiol,2004 ,93( 9A ) :3B-6B.
  • 4Kasim N A, Whitehouse M, Ramachandran C, et al. Mo- lecular properties of WHO essential drugs and provisional biopharmaceutical classification [ J ]. Mol Pharm, 2004, 1 ( 1 ) :85-96.
  • 5Wen X, Tan F, Jing Z, et al. Preparation and study the 1 : 2 inclusion complex of carvedilol with β-cyclodextrin[ J]. J Pharm Biomed Anal,2004,34(3 ) : 517-523.
  • 6Loftsson T, Duch~ne D. Cyclodextrins and their pharma- ceutical applications [ J ]. Int J Pharm, 2007,329 (1/2) : 1-11.
  • 7何忠贵.环糊精包合物技术[M].北京:人民卫生出版社,2008:29-35.
  • 8Bhutani S, Hiremath S N, Swamy P V, et al. Preparation and evaluation of inclusion complexes of carvedilol [ J ]. J Sci Ind Res India,2007,66(10) : 830-834.
  • 9Higuchi T K, Connors K A. Phase solubility techniques [J] .Adv Anal Chem Instrum,1965,4( 2 ) :212-217.
  • 10Stella V J, Rajewski R A. Cyclodextrins: their future in drug formulation and delivery [ J ]. Pharm Res, 1997,14 (5) :556-567.

共引文献12

同被引文献22

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部